Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · IEX Real-Time Price · USD
2.930
+0.040 (1.38%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $160.09 million as of July 26, 2024. Its market cap has increased by 335.03% in one year.
Market Cap
160.09M
Enterprise Value
85.76M
1-Year Change
335.03%
Ranking
Category
Stock Price
$2.93
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $160.09M, a decrease of -56.16%. That is a compound annual growth rate of -23.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 157.90M | 592.54% |
| Dec 29, 2023 | 22.80M | 3.17% |
| Dec 30, 2022 | 22.10M | -84.19% |
| Dec 31, 2021 | 139.80M | -61.71% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InfuSystem Holdings | 148.00M |
| Alpha Tau Medical | 146.63M |
| Zomedica | 146.60M |
| Capricor Therapeutics | 146.15M |
| aTyr Pharma | 142.13M |
| Harvard Bioscience | 140.71M |
| Regencell Bioscience Holdings | 140.53M |
| Myomo | 139.89M |